CDI: Clinical Trials

1 trial for CDI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow CDI: new trials by email Literature Review of CDI trials Research Report on CDI

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
VE303, Placebo - Clostridium Difficile, Clostridium Difficile Infections
Phase 3RecruitingVedanta Biosciences, Inc.8522024-05-202026-09-29

Narrower conditions

Clostridium Infections (1)  ·  Dysentery (1)

Broader conditions

Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Digestive System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Intestinal Diseases (1)

Sponsors

Vedanta Biosciences, Inc. (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Georgia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Ireland (1)  ·  Israel (1)  ·  Italy (1)  ·  Mexico (1)